These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10477166)

  • 21. Comparison of ramosetron and granisetron for the prevention of acute and delayed emesis in Cisplatin-based chemotherapy: a randomized controlled trial.
    Cheirsilpa A; Sinthusake T; Songsakkaesorn A; Visawaprasit S; Chulaka K; Changkuingdee N
    Jpn J Clin Oncol; 2005 Dec; 35(12):695-9. PubMed ID: 16319109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-dose oral granisetron (1 mg) plus intravenous dexamethasone: efficacy in gynecologic cancer patients receiving carboplatin-based chemotherapy.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Gynecol Oncol; 1998 Oct; 71(1):113-5. PubMed ID: 9784330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation.
    Fox-Geiman MP; Fisher SG; Kiley K; Fletcher-Gonzalez D; Porter N; Stiff P
    Biol Blood Marrow Transplant; 2001; 7(11):596-603. PubMed ID: 11760147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective cross-over to granisetron after failure to ondansetron, a randomized double blind study in patients failing ondansetron plus dexamethasone during the first 24 hours following highly emetogenic chemotherapy.
    de Wit R; de Boer AC; vd Linden GH; Stoter G; Sparreboom A; Verweij J
    Br J Cancer; 2001 Oct; 85(8):1099-101. PubMed ID: 11710819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral granisetron solution as prophylaxis for chemotherapy-induced emesis in children: double-blind study of 2 doses].
    Mabro M; Cohn R; Zanesco L; Madon E; Hahlen K; Margueritte G; Breatnach F; Gentet JC; Plouvier é
    Bull Cancer; 2000 Mar; 87(3):259-64. PubMed ID: 10779814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    Birch R; Weaver CH; Carson K; Buckner CD
    Bone Marrow Transplant; 1998 Oct; 22(7):685-8. PubMed ID: 9818697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of granisetron alone and granisetron plus dexamethasone or hydroxyzine hydrochloride for the prevention of nausea and vomiting during chemotherapy including cisplatin].
    Tsukuda M; Kohno H; Enomoto H; Kawai S; Yago T; Matsuda H; Ikema Y; Makino Y; Kubota A; Furukawa M
    Gan To Kagaku Ryoho; 1995 Sep; 22(10):1377-82. PubMed ID: 7668873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomiting.
    Jordan K; Grothey A; Kegel T; Fibich C; Schöbert C
    Onkologie; 2005 Feb; 28(2):88-92. PubMed ID: 15662112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
    Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Granisetron versus granisetron plus methylprednisolone in the prevention of chemotherapy induced nausea and vomiting--in adjuvant chemotherapy, including CDDP against gastric cancer].
    Kurita A; Takashima S; Nakata M; Kubo Y; Saiki T; Ohsumi S; Yokoyama N; Tanada M; Takiyama W; Saeki H
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):49-54. PubMed ID: 9020945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Granisetron vs ondansetron for prevention of nausea and vomiting in hematopoietic stem cell transplant patients: results of a prospective, double-blind, randomized trial.
    Walsh T; Morris AK; Holle LM; Callander N; Bradshaw P; Valley AW; Clark G; Freytes CO
    Bone Marrow Transplant; 2004 Dec; 34(11):963-8. PubMed ID: 15489869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granisetron-dexamethasone combination for multiple day cisplatin.
    Pronzato P; Losardo PL; Vaira F; Vigani A; Landucci M; Ghio E
    Anticancer Res; 1995; 15(5B):2261-3. PubMed ID: 8572634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of granisetron alone and granisetron plus hydroxyzine hydrochloride for the prophylactic treatment of emesis induced by cisplatin-containing chemotherapy].
    Tsukuda M; Kokatsu T; Furukawa S; Kohno H; Kubota A; Furukawa M; Enomoto H
    Gan To Kagaku Ryoho; 1993 Oct; 20(13):2037-41. PubMed ID: 8215478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Herrington JD; Jaskiewicz AD; Song J
    Cancer; 2008 May; 112(9):2080-7. PubMed ID: 18327813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A randomized cross-over comparative study of granisetron alone and combination of granisetron, methylprednisolone and droperidol as antiemetic prophilaxis in CDDP-based chemotherapy for gynecologic cancer].
    Wataba K; Sagae S; Fukunaka N; Sugimura M; Akutagawa N; Hayashi T; Yamana K; Nakamura T; Terasawa K; Mizumoto H; Kitajima Y; Kudo R
    Gan To Kagaku Ryoho; 1997 Apr; 24(6):691-7. PubMed ID: 9126306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omission of day 2 of antiemetic medications is a cost saving strategy for improving chemotherapy-induced nausea and vomiting control: results of a randomized phase III trial.
    Lajolo PP; de Camargo B; del Giglio A
    Am J Clin Oncol; 2009 Feb; 32(1):23-6. PubMed ID: 19194119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy: a double-blind, placebo-controlled, comparative study.
    Goedhals L; Heron JF; Kleisbauer JP; Pagani O; Sessa C
    Ann Oncol; 1998 Jun; 9(6):661-6. PubMed ID: 9681082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ondansetron versus granisetron, both combined with dexamethasone, in the prevention of cisplatin-induced emesis. Italian Group of Antiemetic Research.
    Ann Oncol; 1995 Oct; 6(8):805-10. PubMed ID: 8589019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative trial of oral granisetron and intravenous ondansetron in patients receiving chemotherapy for breast cancer. Study Group of Granisetron].
    Mabro M; Granisétron PK
    Bull Cancer; 1999 Mar; 86(3):295-301. PubMed ID: 10210764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.
    White L; Daly SA; McKenna CJ; Zhestkova N; Leal C; Breatnach F; Smelhaus V; Hung IJ; Kowalczyk J; Ninane J; Mitchell T; Haigh C
    Pediatr Hematol Oncol; 2000 Sep; 17(6):445-55. PubMed ID: 10989464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.